{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:30:40Z","timestamp":1792668640203,"version":"4.5.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic lymphocytic lymphoma (CLL) has one of the highest familial risks among cancers. Monoclonal B-cell lymphocytosis (MBL), the precursor to CLL, has a higher prevalence (13%-18%) in families with 2 or more members with CLL compared with the general population (5%-12%). Although, the rate of progression to CLL for high-count MBLs (clonal B-cell count \u2265500\/\u00b5L) is \u223c1% to 5%\/y, no low-count MBLs have been reported to progress to date. We report the incidence and natural history of MBL in relatives from CLL families. In 310 CLL families, we screened 1045 relatives for MBL using highly sensitive flow cytometry and prospectively followed 449 of them. MBL incidence was directly age- and sex-adjusted to the 2010 US population. CLL cumulative incidence was estimated using Kaplan-Meier survival curves. At baseline, the prevalence of MBL was 22% (235\/1045 relatives). After a median follow-up of 8.1 years among 449 relatives, 12 individuals progressed to CLL with a 5-year cumulative incidence of 1.8%. When considering just the 139 relatives with low-count MBL, the 5-year cumulative incidence increased to 5.7%. Finally, 264 had no MBL at baseline, of whom 60 individuals subsequently developed MBL (2 high-count and 58 low-count MBLs) with an age- and sex-adjusted incidence of 3.5% after a median of 6 years of follow-up. In a screening cohort of relatives from CLL families, we reported progression from normal-count to low-count MBL to high-count MBL to CLL, demonstrating that low-count MBL precedes progression to CLL. We estimated a 1.1% annual rate of progression from low-count MBL, which is in excess of that in the general population.<\/jats:p>","DOI":"10.1182\/blood.2020006322","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T08:33:30Z","timestamp":1608626010000},"page":"2046-2056","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families"],"prefix":"10.1182","volume":"137","author":[{"given":"Susan L.","family":"Slager","sequence":"first","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Lanasa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Duke Cancer Institute, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald E.","family":"Marti","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-1998","authenticated-orcid":false,"given":"Nicola J.","family":"Camp","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Abbasi","sequence":"additional","affiliation":[{"name":"Center for Biologics Research and Evaluation, Food and Drug Administration, Silver Springs, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6614-083X","authenticated-orcid":false,"given":"James B.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada;"},{"name":"Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Call","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-1875","authenticated-orcid":false,"given":"Kari G.","family":"Rabe","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geffen","family":"Kleinstern","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-2072","authenticated-orcid":false,"given":"Nicholas J.","family":"Boddicker","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7314","authenticated-orcid":false,"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Leis","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-8818","authenticated-orcid":false,"given":"Versha","family":"Banerji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada;"},{"name":"Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada;"},{"name":"Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Brander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Duke Cancer Institute, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Glenn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[{"name":"Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-2153","authenticated-orcid":false,"given":"Karen","family":"Curtin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tait D.","family":"Shanafelt","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"McMaster","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-5576","authenticated-orcid":false,"given":"J. Brice","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Duke Cancer Institute, Durham, NC;"},{"name":"Department of Immunology, Duke University Medical Center, Durham, NC;"},{"name":"Durham Veterans Affairs Medical Center, Durham, NC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Caporaso","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2021041515224749600_B1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2021041515224749600_B2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"2021041515224749600_B3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2008-09-176933","article-title":"The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring","volume":"114","author":"Dagklis","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2021041515224749600_B4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","article-title":"Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management","volume":"24","author":"Shanafelt","year":"2010","journal-title":"Leukemia"},{"issue":"S1 Suppl 1","key":"2021041515224749600_B5","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1002\/cyto.b.20533","article-title":"Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)","volume":"78","author":"Rawstron","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"2021041515224749600_B6","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2021041515224749600_B7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V98.1.29","article-title":"Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy","volume":"98","author":"Rawstron","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2021041515224749600_B8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood-2013-08-523704","article-title":"Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding","volume":"123","author":"Shim","year":"2014","journal-title":"Blood"},{"issue":"7","key":"2021041515224749600_B9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"2021041515224749600_B10","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.2008.21.2704","article-title":"Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia","volume":"27","author":"Shanafelt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021041515224749600_B11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"2021041515224749600_B12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"2021041515224749600_B13","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.3324\/haematol.2017.183194","article-title":"Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis","volume":"103","author":"Parikh","year":"2018","journal-title":"Haematologica"},{"issue":"25","key":"2021041515224749600_B14","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2021041515224749600_B15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3324\/haematol.2017.183954","article-title":"Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome","volume":"103","author":"Criado","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2021041515224749600_B16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"issue":"48","key":"2021041515224749600_B17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jncimonographs\/lgu001","article-title":"Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia\/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Slager","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"2021041515224749600_B18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3324\/haematol.2008.003632","article-title":"Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin\u2019s lymphomas among relatives of patients with chronic lymphocytic leukemia","volume":"94","author":"Goldin","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"2021041515224749600_B19","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood-2002-03-0892","article-title":"Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2021041515224749600_B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10013","article-title":"B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia","volume":"52","author":"Marti","year":"2003","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"2021041515224749600_B21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2141.2010.08339.x","article-title":"Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families","volume":"151","author":"Goldin","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"2021041515224749600_B22","doi-asserted-by":"crossref","first-page":"14175","DOI":"10.1038\/ncomms14175","article-title":"Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia","volume":"8","author":"Law","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"2021041515224749600_B23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ng.219","article-title":"A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia","volume":"40","author":"Di Bernardo","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"2021041515224749600_B24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.510","article-title":"Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk","volume":"42","author":"Crowther-Swanepoel","year":"2010","journal-title":"Nat Genet"},{"issue":"6","key":"2021041515224749600_B25","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2010-09-308205","article-title":"Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL","volume":"117","author":"Slager","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2021041515224749600_B26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2012-03-413591","article-title":"Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia","volume":"120","author":"Slager","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2021041515224749600_B27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ng.2652","article-title":"Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2021041515224749600_B28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.2843","article-title":"A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia","volume":"46","author":"Speedy","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2021041515224749600_B29","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1038\/ncomms10933","article-title":"Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia","volume":"7","author":"Berndt","year":"2016","journal-title":"Nat Commun"},{"issue":"8","key":"2021041515224749600_B30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/10428190903026492","article-title":"Autoimmune cytopenia in chronic lymphocytic leukemia\/small lymphocytic lymphoma: changes in clinical presentation and prognosis","volume":"50","author":"Zent","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2021041515224749600_B31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.seminoncol.2016.02.009","article-title":"Prognostic factors and risk stratification in chronic lymphocytic leukemia","volume":"43","author":"Parikh","year":"2016","journal-title":"Semin Oncol"},{"issue":"1","key":"2021041515224749600_B32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2011.09010.x","article-title":"Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL","volume":"157","author":"Kern","year":"2012","journal-title":"Br J Haematol"},{"issue":"11","key":"2021041515224749600_B33","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2021041515224749600_B34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2016.172","article-title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome","volume":"31","author":"Barrio","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"2021041515224749600_B35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.semcancer.2010.08.005","article-title":"CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?","volume":"20","author":"Scarf\u00f2","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"2021041515224749600_B36","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2017-11-814608","article-title":"Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis","volume":"131","author":"Kleinstern","year":"2018","journal-title":"Blood"},{"issue":"26","key":"2021041515224749600_B37","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1182\/blood-2010-07-294975","article-title":"Inherited genetic susceptibility to monoclonal B-cell lymphocytosis [published correction appears in Blood. 2011;117(12):3477]","volume":"116","author":"Crowther-Swanepoel","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2021041515224749600_B38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2012.187","article-title":"Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls","volume":"27","author":"Moreira","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"2021041515224749600_B39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/leu.2015.235","article-title":"Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis","volume":"30","author":"Solomon","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"2021041515224749600_B40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.mayocp.2013.06.006","article-title":"The Mayo Clinic Biobank: a building block for individualized medicine","volume":"88","author":"Olson","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"2021041515224749600_B41","article-title":"Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL) [published online ahead of print 18 March 2020]","author":"Shanafelt","journal-title":"Leukemia"},{"issue":"8","key":"2021041515224749600_B42","first-page":"1117","article-title":"Clinical features and outcome of familial chronic lymphocytic leukemia","volume":"91","author":"Mauro","year":"2006","journal-title":"Haematologica"},{"issue":"12","key":"2021041515224749600_B43","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1182\/blood-2008-03-142349","article-title":"Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL","volume":"111","author":"Crowther-Swanepoel","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/15\/2046\/1805037\/bloodbld2020006322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/15\/2046\/1805037\/bloodbld2020006322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T23:57:55Z","timestamp":1618617475000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/15\/2046\/474760\/Natural-history-of-monoclonal-B-cell-lymphocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":43,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020006322","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}